Timing of the bid is excellent for the overseas bidder - share price around multi-year lows and a weak Aussie dollar are a good combo.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago